arrow
M

Maura Campitelli

department of radiation oncology
H指数:15
被引数:735

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

REASSESSING THE RISKS: TOXICITY PROFILE OF STEREOTACTIC ABLATIVE RADIOTHERAPY AFTER BEVACIZUMAB IN OLIGOMETASTATIC OVARIAN CANCER – A NEW PERSPECTIVE FOR RADIATION ONCOLOGISTS?

重新评估风险:在寡转移性卵巢癌中,经贝伐珠单抗治疗后立体定向消融放射治疗的毒性特征——这对放射肿瘤学家而言是否是一种新的视角?

2025-12-160
OA
Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?

在局部晚期宫颈癌(BRILACC)中,化疗放疗后评估反应的最佳时机是什么?

2025-09-120
OA
MRI-guided stereotactic radiotherapy for oligometastatic peritoneal carcinomatosis: toward integrative oncologic approaches

MRI引导的立体定向放疗用于寡转移性腹膜癌:迈向整合肿瘤学方法

2025-06-120
PRE
Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)
2024-08-280
OAAI
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study
2024-02-013
PRE
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images
2022-09-0113
PRE
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates

EROS 2.0研究: 子宫内膜癌两种介入放疗 (近距离放射治疗) 方案的评估: 晚期阴道毒性发生率的比较

2022-01-296
OAAI
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study
2019-08-1417
PREAI